30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
Canada Food & Drug Retailing

PharmaCorp Rx Inc (PCRX)

Track

The most recent insider trading activity at PharmaCorp Rx Inc. occurred on November 12, 2025. Directors and a Senior Officer made multiple significant purchases, totaling over $1.7 million. These transactions represent a notable increase in insider holdings, with all reported trades being buy orders.
Stock chart
Ticker: PCRX Exchange: CVE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Simpson, Alan Arthur
Director of Issuer
1 purchase — total 1,000,003 CAD
Buy 12 Nov 2025
Value CA$530,095.06 | Price 429.99 | Shares 90,735
Buy 12 Nov 2025
Value CA$4,950,042.63 | Price 14.17 | Shares 4,897
Buy 12 Nov 2025
Value CA$4,350,878.38 | Price 450.92 | Shares 74,581
Buy 12 Nov 2025
Value CA$24,990.00 | Price 0.42 | Shares 59,500
Buy 12 Nov 2025
Value CA$30,034.20 | Price 0.42 | Shares 71,510
Buy 12 Nov 2025
Value CA$100,002.00 | Price 0.42 | Shares 238,100
Buy 12 Nov 2025
Value CA$99,960.00 | Price 0.42 | Shares 238,000
Buy 12 Nov 2025
Value CA$250,000.80 | Price 0.42 | Shares 595,240
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-14 2025-11-12 B Purchase
2.6
Simpson, Alan Arthur

Director of Issuer

Non-Executive Director
90,735 -49.7%
429.99
CA$530,095 		90,735 -49.7% 429.99 CA$530,095
2025-11-14 2025-11-12 B Purchase
2.1
Dumont, James

Director of Issuer

Non-Executive Director
4,897
14.17
CA$4,950,043 		4,897 14.17 CA$4,950,043
2025-11-14 2025-11-12 B Purchase
2.1
Dumont, James

Director of Issuer

Non-Executive Director
74,581 +11.7%
450.92
CA$4,350,878 		74,581 +11.7% 450.92 CA$4,350,878
2025-11-13 2025-11-12 B Purchase
2.1
Hladun, Grant Warren

Director of Issuer

Non-Executive Director
59,500 +11.9%
0.42
CA$24,990 		59,500 +11.9% 0.42 CA$24,990
2025-11-13 2025-11-12 B Purchase
2.1
Hladun, Grant Warren

Director of Issuer

Non-Executive Director
71,510
0.42
CA$30,034 		71,510 0.42 CA$30,034
2025-11-13 2025-11-12 B Purchase
2.1
Dale, Paul Richard

Senior Officer of Issuer

Officer
238,100
0.42
CA$100,002 		238,100 0.42 CA$100,002
2025-11-13 2025-11-12 B Purchase
2.1
Brownell, Kenneth Alva

Director of Issuer

Non-Executive Director
238,000 +64.0%
0.42
CA$99,960 		238,000 +64.0% 0.42 CA$99,960
2025-11-13 2025-11-12 B Purchase
2.1
Brown, Grady Douglas

Director of Issuer

Non-Executive Director
595,240 +190.5%
0.42
CA$250,001 		595,240 +190.5% 0.42 CA$250,001
Explore more

More insider trading research around PharmaCorp Rx Inc

More insider trades in Canada
Similar Consumer Non-Cyclicals companies with insider activity
More Food & Drug Retailing companies with insider activity
More Food & Drug Retailing companies with insider activity
Insider trading in North America